In vivo, NASH alleviation significantly correlated with the suppression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis and downregulated hepatic DPP4 expression. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatohepatitis.